Oxford Immunotec Appoints Stephen M. Gansler as Senior Vice President and Global Head of Human Resources
(Thomson Reuters ONE) -
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 17, 2015 (GLOBE NEWSWIRE)
-- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global commercial-stage
diagnostics company focused on developing and commercializing proprietary tests
for the management of immune-regulated conditions, today announced that Stephen
M. Gansler has joined the Company as Senior Vice President and Global Head of
Human Resources. Mr. Gansler brings to Oxford Immunotec more than 25 years of
experience in managing and leading the human resource function at life sciences
companies. Most recently, Mr. Gansler was Senior Vice President, Human
Resources, for Millennium Pharmaceuticals, where he played a key leadership role
in the company's growth. During his tenure with Millennium, it was consistently
ranked as one of the best places to work in the United States. Before joining
Millennium, Mr. Gansler spent more than 20 years with Johnson & Johnson, holding
a variety of roles of increasing responsibility, including the head of human
resources for four separate business units, and successfully leading several
post-acquisition integrations.
"Oxford Immunotec is a fast growing leader in the field of immunology-based
diagnostics and I am excited about the opportunity to play a role in its
continued growth and success," said Mr. Gansler.
"Steve brings a wealth of human resource management knowledge, leadership and
general management expertise to Oxford Immunotec," said CEO, Dr. Peter Wrighton-
Smith. "We are very pleased to have him join our team and look forward to his
significant contribution to our continued growth and success."
Mr. Gansler received his Bachelor Industrial Administration from the General
Motors Institute and a Master of Business Administration-Finance and Juris
Doctor from Seton Hall University.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company
focused on developing and commercializing proprietary tests for the management
of immune-regulated conditions. The Company's initial product is the T-
SPOT(®).TB test, which is used to test for latent tuberculosis infection. The
T-SPOT.TB test has been approved for sale in over 50 countries, including the
United States, where it has received pre-market approval from the Food and Drug
Administration, Europe, where it has obtained a CE mark, as well as Japan and
China. The Company has seven active development programs, each of which
leverages our T cell and innate immune measuring technology. The two most
advanced products are focused on the transplantation market. The Company is
headquartered near Oxford, UK and in Marlborough, MA. Additional information
can be found at www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
CONTACTS:
For Media Inquiries:
Caroline Crawley
Oxford Immunotec
Tel: +44 1235 442796
ccrawley(at)oxfordimmunotec.com
For Investor Inquiries:
Rick Altieri
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
raltieri(at)oxfordimmunotec.com
Mark Klausner
Westwicke Partners
Tel: +1 (443) 213-0500
oxfordimmunotec(at)westwicke.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Oxford Immunotec via GlobeNewswire
[HUG#1904248]
Unternehmensinformation / Kurzprofil:
Datum: 17.03.2015 - 16:58 Uhr
Sprache: Deutsch
News-ID 379200
Anzahl Zeichen: 4081
contact information:
Town:
Oxfordshire
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 159 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Oxford Immunotec Appoints Stephen M. Gansler as Senior Vice President and Global Head of Human Resources"
steht unter der journalistisch-redaktionellen Verantwortung von
Oxford Immunotec (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
